Evidence map›Paper›PMID 26474763›Full record

ArticlePharmaceutical research2016

Factors Governing the Precision of Subvisible Particle Measurement Methods - A Case Study with a Low-Concentration Therapeutic Protein Product in a Prefilled Syringe.

Anacelia Ríos Quiroz, Jens Lamerz, Thierry Da Cunha, Adeline Boillon, Michael Adler, Christof Finkler, Joerg Huwyler, Roland Schmidt, Hanns-Christian Mahler, Atanas V Koulov

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anacelia Ríos QuirozPharmaceutical Development & Supplies, Pharma Technical Development Biologics Europe, F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland.
Jens LamerzPharma Development, Biometry, NonClinical Biostatistics, F. Hoffmann - La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, Switzerland.
Thierry Da CunhaAnalytical Development & Quality Control, Pharma Technical Development Biologics Europe, F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland.
Adeline BoillonPharmaceutical Development & Supplies, Pharma Technical Development Biologics Europe, F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland.
Michael AdlerPharmaceutical Development & Supplies, Pharma Technical Development Biologics Europe, F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland.
Christof FinklerAnalytical Development & Quality Control, Pharma Technical Development Biologics Europe, F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland.
Joerg HuwylerDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, 4056, Basel, Switzerland.
Roland SchmidtPharmaceutical Development & Supplies, Pharma Technical Development Biologics Europe, F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland.
Hanns-Christian MahlerPharmaceutical Development & Supplies, Pharma Technical Development Biologics Europe, F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland.
Atanas V KoulovAnalytical Development & Quality Control, Pharma Technical Development Biologics Europe, F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland. atanas.koulov@roche.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe current study was performed to assess the precision of the principal subvisible particle measurement methods available today. Special attention was given to identifying the sources of error and the factors governing analytical performance.

methodsThe performance of individual techniques was evaluated using a commercial biologic drug product in a prefilled syringe container. In control experiments, latex spheres were used as standards and instrument calibration suspensions.

resultsThe results reported in this manuscript clearly demonstrated that the particle measurement techniques operating in the submicrometer range have much lower precision than the micrometer size-range methods. It was established that the main factor governing the relatively poor precision of submicrometer methods in general and inherently, is their low sampling volume and the corresponding large extrapolation factors for calculating final results.

conclusionsThe variety of new methods for submicrometer particle analysis may in the future support product characterization; however, the performance of the existing methods does not yet allow for their use in routine practice and quality control.

Indexed as

Chemistry Techniques, AnalyticalParticle SizeProtein AggregatesProteinsSyringesProtein AggregatesProteinsparticle counting methodsprecisionprotein particlessubvisible particles

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.